Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.
Science Speaks highlights remarks made at a congressional briefing to release GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D.
The Regulatory Affairs Professionals Society's (RAPS) Regulatory Focus explores the regulatory policy actions recommended in GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D, including a recommendation for the US Food and Drug Administration to create a mechanism to review health products for use outside the United States.
When existing market forces alone fall short in ensuring availability of and access to lifesaving health tools, a range of interventions are needed to alter the market and ultimately change the behavior of its actors.
On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.